Outlook for Pharma in 2018
Interactive Video
•
Business, Health Sciences, Biology
•
University
•
Hard
Wayground Content
FREE Resource
The video discusses the anticipated developments in the pharmaceutical industry for 2018, focusing on large phase three trials in lung cancer by major companies like Rausch, Merck, and Bristol Myers. It highlights the market risks associated with these trials, particularly for Merck, and the potential impact of M&A activities and currency fluctuations. The video concludes with expectations for the upcoming JP Morgan healthcare conference.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What expectations are set for the year 2018 regarding drug trials and company performance?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
Discuss the implications of currency strength on pharmaceutical companies as mentioned in the text.
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
